EDGAR Filing Documents for 0001564590-17-005329

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001564590-17-005329

Filing Date

2017-03-27

Accepted

2017-03-27 16:12:52

Documents

101

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K/A	srne-10ka_20161231.htm	10-K/A	2435773
2	EX-23.3	srne-ex233_282.htm	EX-23.3	2984
3	EX-31.3	srne-ex313_82.htm	EX-31.3	21648
4	EX-31.4	srne-ex314_83.htm	EX-31.4	21643
5	EX-32.2	srne-ex322_84.htm	EX-32.2	16869
	Complete submission text file	0001564590-17-005329.txt		12483702

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	srne-20161231.xml	EX-101.INS	2875372
7	XBRL TAXONOMY EXTENSION SCHEMA	srne-20161231.xsd	EX-101.SCH	100347
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	srne-20161231_cal.xml	EX-101.CAL	91121
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	srne-20161231_def.xml	EX-101.DEF	419693
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	srne-20161231_lab.xml	EX-101.LAB	759819
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	srne-20161231_pre.xml	EX-101.PRE	640287

Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121

Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)